FLCN


Summary: This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
folliculinMIM:607273Ensembl:ENSG00000154803HGNC:HGNC:27310PA13490100517p11.2

GO terms in FLCN


Term TypeEvidence TypeGO Term IDGO Des.
BPIDAGO:0000122negative regulation of transcription by RNA polymerase II
BPIMPGO:0000122negative regulation of transcription by RNA polymerase II
BPISSGO:0001701in utero embryonic development
BPIDAGO:0001932regulation of protein phosphorylation
BPISSGO:0001934positive regulation of protein phosphorylation
BPISSGO:0007043cell-cell junction assembly
BPIMPGO:0010508positive regulation of autophagy
BPISSGO:0010629negative regulation of gene expression
BPISSGO:0010823negative regulation of mitochondrion organization
BPISSGO:0030097hemopoiesis
BPIDAGO:0030308negative regulation of cell growth
BPIMPGO:0030336negative regulation of cell migration
BPIDAGO:0030511positive regulation of transforming growth factor beta receptor signaling pathway
BPISSGO:0030511positive regulation of transforming growth factor beta receptor signaling pathway
BPIMPGO:0031929TOR signaling
BPISSGO:0032006regulation of TOR signaling
BPISSGO:0032007negative regulation of TOR signaling
BPISSGO:0032008positive regulation of TOR signaling
BPIMPGO:0032465regulation of cytokinesis
BPIMPGO:0035024negative regulation of Rho protein signal transduction
BPISSGO:0035065regulation of histone acetylation
BPISSGO:0043065positive regulation of apoptotic process
BPIMPGO:0045785positive regulation of cell adhesion
BPIDAGO:0045944positive regulation of transcription by RNA polymerase II
BPIMPGO:0045944positive regulation of transcription by RNA polymerase II
BPISSGO:0051898negative regulation of protein kinase B signaling
BPISSGO:0070373negative regulation of ERK1 and ERK2 cascade
BPISSGO:0097009energy homeostasis
BPIDAGO:1900181negative regulation of protein localization to nucleus
BPISSGO:1901723negative regulation of cell proliferation involved in kidney development
BPISSGO:2000973regulation of pro-B cell differentiation
BPISSGO:2001170negative regulation of ATP biosynthetic process
CCIDAGO:0005634nucleus
CCIDAGO:0005737cytoplasm
CCTASGO:0005764lysosome
CCIDAGO:0005829cytosol
CCIDAGO:0005886plasma membrane
CCTASGO:0005929cilium
CCIDAGO:0030496midbody
CCIDAGO:0044291cell-cell contact zone
MFIEAGO:0005085guanyl-nucleotide exchange factor activity
MFIPIGO:0005515protein binding
MFIDAGO:0044877protein-containing complex binding

Gene expression in normal tissue: FLCN

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in FLCN


DatabasePathway IDPathway Des.
kegghsa04150mTOR signaling pathway - Homo sapiens (human)
kegghsa05211Renal cell carcinoma - Homo sapiens (human)

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD512nutlin 36
iGMDRD310Everolimus4
iGMDRD468AZ6281
iGMDRD213SMR0000686503
iGMDRD232FTI-2771
iGMDRD536PLX-47201
iGMDRD152179324-69-71
iGMDRD366PI-1033
iGMDRD132(-)-gallocatechin-3-O-gallate3

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in FLCN

​​​​